Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and HDAC

Nesteruk, K., Smits, R., Bruno, M., Peppelenbosch, M. P., & Fuhler, G. M. (2020). Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and HDAC. Pancreatology, 20(3), 558–561. https://doi.org/10.1016/j.pan.2019.12.019